Dermatologist Brings Unique Expertise to Patients with Autoimmune Disease

David Pearson, MD, recently joined the Department of Dermatology as an Assistant Professor, bringing unique expertise in clinical care and research related to autoimmune connective tissue and autoimmune bullous diseases. He will be treating patients at the Dermatology Clinic at the Clinics and Surgery Center (CSC).

A Minnesota native, Dr. Pearson trained under Victoria Werth, MD, an internationally-renowned expert in dermatomyositis, cutaneous lupus, and pemphigus, during his rheumatologic dermatology fellowship at the University of Pennsylvania. As a fellow, he was the sub-investigator in numerous industry-sponsored clinical trials for dermatomyositis, lupus, and pemphigus, and engaged in investigator-initiated studies examining environmental triggers and systemic manifestations of dermatomyositis, quality of life metrics in autoimmune connective tissue disease, and the validation of disease severity indices in pediatric populations. He is currently the only fellowship-trained rheumatologic dermatologist in the state, and only one of few building a clinical practice around this patient population.

His focus on autoimmune disease brings an added dimension to the multidisciplinary team of rheumatologists, pulmonologists and nephrologist treating patients at the Clinics and Surgery Center. Together, they will support the University of Minnesota Medical School’s efforts in developing its regional and national reputation as a center for autoimmune connective tissue diseases.

Dr. Pearson is currently seeking patients with dermatomyositis, cutaneous lupus, systemic sclerosis, morphea, vasculitis, pemphigus, pemphigoid, and other autoimmune connective tissue diseases.

His clinical interests include providing evidence-based and compassionate care for patients with autoimmune connective tissue and autoimmune bullous diseases. He conducts clinical research and studies exogenous triggers for autoimmune connective tissue diseases including dermatomyositis, cutaneous lupus, and systemic sclerosis. He plans to partner with industry to develop and study treatments for these debilitating conditions.

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”